1. Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas. Issue 3 (2nd March 2021) Authors: Dimou, Maria; Papageorgiou, Sotirios G.; Stavroyianni, Niki; Katodritou, Eirini; Tsirogianni, Maria; Kalpadakis, Christina; Banti, Anastasia; Arapaki, Maria; Iliakis, Theodoros; Bouzani, Maria; Verrou, Eugenia; Spanoudakis, Emmanouil; Giannouli, Stavroula; Marinakis, Theodoros; Mandala, Evdokia; ... Journal: Hematological oncology Issue: Volume 39:Issue 3(2021) Page Start: 336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗